18,984 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by DnB Asset Management AS

DnB Asset Management AS acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 18,984 shares of the company's stock, valued at approximately $641,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC lifted its position in shares of Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock worth $7,537,000 after buying an additional 539 shares in the last quarter. Prestige Wealth Management Group LLC raised its holdings in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after acquiring an additional 965 shares in the last quarter. Farther Finance Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter valued at approximately $34,000. First Horizon Advisors Inc. grew its holdings in shares of Tempus AI by 207.9% in the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after purchasing an additional 1,108 shares in the last quarter. Finally, FNY Investment Advisers LLC purchased a new position in shares of Tempus AI in the fourth quarter valued at $67,000. Institutional investors own 24.22% of the company's stock.

Analyst Upgrades and Downgrades

TEM has been the subject of several research reports. Morgan Stanley increased their price objective on shares of Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Wolfe Research lowered Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. William Blair reissued a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Needham & Company LLC raised their price objective on Tempus AI from $56.00 to $70.00 and gave the company a "buy" rating in a research note on Tuesday, February 25th. Finally, Loop Capital cut their target price on Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $61.18.

Remove Ads

Insider Activity

In other Tempus AI news, Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the transaction, the director now owns 26,514 shares in the company, valued at approximately $1,207,447.56. This represents a 10.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 20,000 shares of the business's stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $39.61, for a total transaction of $792,200.00. Following the sale, the chief operating officer now directly owns 982,442 shares in the company, valued at $38,914,527.62. This trade represents a 2.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,601,969 shares of company stock worth $317,330,782.

Tempus AI Stock Down 7.8 %

Shares of TEM stock traded down $3.59 on Friday, hitting $42.58. The stock had a trading volume of 11,548,799 shares, compared to its average volume of 5,329,069. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The business has a 50 day moving average price of $58.45 and a 200 day moving average price of $51.51. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.